Safety and efficacy of PD-1 inhibitors in HIV-infected patients with severe comorbidities: a prospective observational cohort study

Chin Med J (Engl). 2023 Nov 20;136(22):2750-2752. doi: 10.1097/CM9.0000000000002883. Epub 2023 Oct 25.

Authors

Xueling Zhu¹, Xiang Liu, Zhikai Wan, Jiangjin Hui, Ran Tao, Xiaorong Peng, Junwei Su, Ying Huang, Biao Zhu

Affiliation

¹ Department of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China.

No abstract available

Publication types

Observational Study
Letter

MeSH terms

Anti-HIV Agents* / therapeutic use
Comorbidity
HIV Infections* / drug therapy
Humans
Immune Checkpoint Inhibitors / therapeutic use
Prospective Studies

Substances

Immune Checkpoint Inhibitors
Anti-HIV Agents